Научно-практический журнал
«Клиническая физиология кровообращения»

Главный редактор

Лео Антонович Бокерия, доктор медицинских наук, профессор, академик РАН и РАМН, директор ФГБУ «НМИЦССХ им. А.Н. Бакулева» МЗ РФ

Головная боль и сердечно-сосудистые заболевания

Авторы: Емец Е.В.1,2, 2, Шумилина М.В. 1

Организация:
1 Институт подготовки кадров высшей квалификации и профессионального образования ФГБУ «Национальный медицинский исследовательский центр сердечно-сосудистой хирургии им. А.Н. Бакулева» (президент – академик РАН и РАМН Л.А. Бокерия) Минздрава России, Рублевское ш., 135, Москва, 121552, Российская Федерация
2 БУЗ Воронежской области «Воронежская областная клиническая больница № 1, Московский пр-т, 151, Воронеж, 394066, Российская Федерация

Для корреспонденции: Сведения доступны для зарегистрированных пользователей.

Раздел: Обзоры

DOI: https://doi.org/10.24022/1814-6910-2021-18-1-16-23

УДК: 616.857+616.1

Библиографическая ссылка: Клиническая физиология кровообращения. 2021; 1 (18): 16-23

Цитировать как: Емец Е.В., Шумилина М.В. . Головная боль и сердечно-сосудистые заболевания. Клиническая физиология кровообращения. 2021; 1 (18): 16-23. DOI: 10.24022/1814-6910-2021-18-1-16-23

Ключевые слова: мигрень, сердечная цефалгия, сердечно-сосудистые заболевания

Поступила / Принята к печати:  13.11.2020 / 27.10.2020

Полнотекстовая версия:
Оформить подписку 🔒

Аннотация

Головная боль (особенно мигрень с аурой) последовательно связана с повышенным риском сердечно-сосудистых заболеваний. Точные патофизиологические механизмы ассоциаций головной боли с сердечно-сосудистой патологией остаются неясными, а литературные данные часто противоречивы. Тем не менее мигрень с аурой связана с факторами свертывания крови и системной дисфункцией эндотелия сосудов, которые могут увеличить риск артериального тромбоза и инфаркта миокарда. Также у лиц с мигренью (особенно с аурой) имеется повышенный риск развития сопутствующих заболеваний и осложнений (например, артериальной диссекции), которые могут способствовать или вызывать инфаркт миокарда. Кроме того, изменения в сердечно-сосудистой системе и ишемическом пороге сердечной мышцы у людей, страдающих от мигрени с аурой, могут увеличить риск инфаркта миокарда, особенно в условиях сосудистого стресса (например, артериальной эмболии). Ключевые слова: мигрень, сердечная цефалгия, сердечно-сосудистые заболевания.

Литература

  1. Vos Th., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M. et al. Years lived with disability Обзоры 21 Клиническая физиология кровообращения. 2021; 18 (1). DOI: 10.24022/1814-6910-2021-18-1-16-23(YLD) for 1160 squealed of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2163–96. DOI: 10.1016/S0140-6736(12)61729-2
  2. GBD 2015 Neurological Disorders Collaborator Group Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017; 16 (11): 877–89.
  3. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018; 38 (1): 1–211. DOI: 10.1177/0333102417738202
  4. Sacco S., Ornello R., Ripa P., Tiseo C., Degan D., Pistoia F. et al. Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies. Eur. J. Neurol. 2015; 22: 1001–11. DOI: 10.1111/ene.12701
  5. Kurth T., Winter A.C., Eliassen A.H., Dushkes R., Mukamal K.J., Rimm E.B. et al. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ. 2016; 353: i2610. DOI: 10.1136/bmj.i2610 6. Linstra K.M., Ibrahimi K., Terwindt G.M., Wermer M.J.H., MaassenVanDenBrink A. Migraine and cardiovascular disease in women. Maturitas. 2017; 97: 28–31. DOI: 10.1016/j.maturitas.2016.12.008
  6. Mahmoud A.N., Mentias A., Elgendy A.Y., Qazi A., Barakat A.F., Saad M. et al. Migraine and the risk of cardiovascular and cerebrovascular events: a metaanalysis of 16 cohort studies including 1 152 407 subjects. BMJ. 2018; 8: e020498. DOI: 10.1136/bmjopen2017-020498
  7. Adelborg K., Szépligeti S.K., Holland-Bill L., Ehrenstein V., Horváth-Puhó E., Henderson V.W. et al. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study. BMJ. 2018; 360: k96. DOI: 10.1136/bmj.k96 9. Sen S., Androulakis X.M., Duda V., Alonso A., Chen L.Y., Soliman E.Z. et al. Migraine with visual aura is a risk factor for incident atrial fibrillation: a cohort study. Neurology. 2018; 91: e2202–10. DOI: 10.1212/WNL.0000000000006650
  8. Elgendy I.Y., Nadeau S.E., Merz C.N., Pepine C.J. Migraine headache: an under-appreciated risk factor for cardiovascular disease in women. J. Am. Heart Ass. 2019; 8: e014546. DOI: 10.1161/JAHA.119.014546
  9. Saeed A., Rana K.F., Warriach Z.I., Tariq M.A. Association of migraine and ischemic heart disease: a review. Cureus. 2019; 11 (9): e5719. DOI: 10.7759/cureus.5719
  10. Kurth T., Rohmann J.L., Shapiro R.E. Migraine and risk of cardiovascular disease. BMJ. 2018; 360: k275. DOI: 10.1136/bmj.k275
  11. Hippisley-Cox J., Coupland C., Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017; 357: j2099. DOI: 10.1136/bmj.j2099
  12. O/ie L.R., Kurth T., Gulati S., Dodick D.W. Migraine and risk of stroke. J. Neurol. Neurosurg. Psych. 2020; 91: 593–604. DOI: 10.1136/jnnp-2018-318254
  13. Elseweidy M.M. The cause of the morning headache is a violation of the venous outflow from the head due to the oncoming flow therapeutic potential of 10-DHGD and/or Pentoxifyllin against aorta calcification in high dietary cholesterol-fed rabbits. Abstract. In: Second International Conference on Dental and Oral Health. 2018, November 26–27; Madrid, Spain.
  14. Ermoshkin V.I. The cause of the morning headache is a violation of the venous outflow from the head due to the oncoming flow. J. Biomed. Pharm. Sci. 2018; 1 (2): 113–5. 17. Ermoshkin V.I. The new theory of heart failure. London; 2017: 15–7. http://heartcongress.conference series.com/europe/abstract/2017/the-new-theoryofheart-failure (дата обращения 17.03.2017)
  15. Folsom A.R., Lutsey P.L., Misialek J.R., Cushman M. A prospective study of migraine history and venous thromboembolism in older adults. Res. Pract. Thromb. Haemost. 2019; 3 (3): 357–63. DOI: 10.1002/rth2.12200
  16. Siegerink B., Rohmann J.L. Impact of your results: beyond the relative risk. Res. Pract. Thromb. Haemost. 2018; 2: 653–57. DOI: 10.1002/rth2.12148 20. Siegerink B., Adelborg K. Migraine and venous thrombosis: another important piece of the puzzle. Res. Pract. Thromb. Haemost. 2019; 3 (3): 309–11. DOI: 10.1002/rth2.12209
  17. Peng K.P., Chen Y.T., Fuh J.L., Tang C.H., Wang S.J. Association between migraine and risk of venous thromboembolism: a nationwide cohort study. Headache. 2016; 56: 1290–9. DOI: 10.1111/head.12885
  18. Asvestas D., Vlachos K., Salachas A., Letsas K.P., Sideris A. Headache: an unusual presentation of acute myocardial infraction. World J. Cardiol. 2014; 6: 514–6. DOI: 10.4330/wjc.v6.i6.514
  19. Wassef N., Ali A.T., Katsanevaki A.Z., Nishtar S. Cardiac cephalgia. Cardiol. Res. 2014; 5: 195–7. DOI: 10.14740/cr361w
  20. Chowdhury A.W., Saleh M.A.D., Hasan P., Amin M.G., Khan T.A., Sabah K.M.N., Kabir S.R. Cardiac cephalgia: a headache of the heart. J. Cardiol. Cases. 2015; 11: 139–41. DOI: 10.1016/j.jccase.2015.02.002
  21. Huang C.C., Liao P.C. Heart attack causes headache – cardiac cephalalgia. Acta Cardiol. Sin. 2016; 32: 239–42. DOI: 10.6515/acs20150628a
  22. MacIsaac R., Jarvis S., Busche K. A case of a cardiac cephalgia. Can. J. Neurol. Sci. 2019; 46: 124–6. DOI: 10.1017/cjn.2018.377
  23. Dell’Aquila A., Sciatti E., Vizzardi E., Metra M. The brain-heart connection: a multiple sclerosis relapse presenting as Takotsubo Syndrome. A case report and literature review. Monaldi Arch. Chest. Dis. 2020; 90 (1): 143–7. DOI: 10.4081/monaldi.2020.1153
  24. Bi Y.C., Gong L. Headache and sick sinus syndrome: a case report. World J. Clin. Cases. 2020; 8 (12): 2629–33. DOI: 10.12998/wjcc.v8.i12.2629
  25. Takagi H., Umemoto T. A meta-analysis of case-control studies of the association of migraine and patent foramen ovale. J. Cardiol. 2016; 67: 493–503. DOI: 10.1016/j.jjcc.2015.09.016
  26. West B.H., Noureddin N., Mamzhi Y., Low C.G., Coluzzi A.C., Shih E.J. et al. Frequency of patent foramen ovale and migraine in patients with cryptogenic stroke. Stroke. 2018; 49: 1123–8. DOI: 10.1161/strokeaha.117.020160 31. Biasco L., Infantino V., Orzan F., Vicentini S., Rovera Ch., Longo G. et al. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt. Am. J. Cardiol. 2014; 64: 390–4. DOI: 10.1016/j.jjcc.2014.02.023
  27. Mattle H.P., Evers S., Hildick-Smith D., Becker W.J., Baumgartner H., Chataway J. et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur. Heart J. 2016; 37: 2029–36. DOI: 10.1093/eurheartj/ehw027
  28. Tobis J.M., Charles A., Silberstein S.D., Sorensen S., Maini B., Horwitz Ph.A. et al. Percutaneous closure of patent foramen ovale in patients with migraine: the premium trial. J. Am. Coll. Cardiol. 2017; 70: 2766–74. DOI: 10.1016/j.jacc.2017.09.1105
  29. Sommer R.J., Nazif T., Privitera L., Robbins B.T. Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale. Neurology. 2018; 91: 1002–09. DOI: 10.1212/WNL.0000000000006572
  30. Androulakis X.M., Kodumuri N., Giamberardino L.D., Rosamond W.D., Gottesman R.F., Yim E. et al. Ischemic stroke subtypes and migraine with visual aura in the ARIC study. Neurology. 2016; 87: 2527–32. DOI: 10.1212/WNL.0000000000003428
  31. Табеева Г.Р. Головная боль: Руководство для врачей. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа; 2018. [Tabeeva G.R. Headache: Guide for doctors. 2nd ed., reprint. and add. Moscow: GEOTAR-Media; 2018 (in Russ.).
  32. Табеева Г.Р. Головная боль. М.: ГЭОТАР-Медиа; 2020. https://www.rosmedlib.ru/book/ISBN 9785970458648.html (дата обращения 10.11.2020) [Tabeeva G.R. Headache. Moscow: GEOTAR-Media; 2020 (in Russ.). https://www.rosmedlib.ru/book/ISBN9785970458648.html (accessed 10.11.2020)
  33. Ramadan N.M. Headache caused by raised intracranial pressure and intracranial hypotension. Curr. Opin. Neurol. 1996; 9: 214–8. DOI: 10.1097/00019052- 199606000-00011 39. Lipton R.B., Lowenkopf T., Bajwa Z.H., Leckie R.S., Ribeiro S., Newman L.C., Greenberg M.A. Cardiac cephalgia: a treatable form of exertional headache. Neurology. 1997; 49: 813–6. DOI: 10.1212/wnl.49.3.813
  34. Bini A., Evangelista A., Castellini P., Lambru G., Ferrante T., Manzoni G.C., Torelli P. Cardiac cephalgia. J. Headache Pain. 2009; 10: 3–9. DOI: 10.1007/s10194-008-0087-x
  35. Sacco S., Ripa P., Grassi D., Pistoia F., Ornello R., Carolei A. et al. Peripheral vascular dysfunction in migraine: a review. J. Head. Pain. 2013; 14: 80. DOI: 10.1186/1129-2377-14-80
  36. Butt J.H., Franzmann U., Kruuse C. Endothelial function in migraine with aura – a systematic review. Headache. 2015; 55: 35–54. DOI: 10.1111/head.12494
  37. Rambarat C., Elgendy I., Johnson B., Reis S.E., Thompson D.V., Sharaf B.L. et al. Migraine headache and long-term cardiovascular outcomes: an extended follow-up of the women’s ischemia syndrome evaluation. Am. J. Med. 2017; 130: 738–43. DOI: 10.1016/j.amjmed.2016.12.028
  38. Tietjen G.E., Khubchandani J. Vascular biomarkers in migraine. Cephalalgia. 2015; 35: 95–117. DOI: 10.1177/0333102414544976 45. Tietjen G.E., Collins S.A. Hypercoagulability and migraine. Headache. 2018; 58: 173–83. DOI: 10.1111/head.13044
  39. Iljazi A., Ayata C., Ashina M., Hougaard A. The role of endothelin in the pathophysiology of migraine – a systematic review. Curr. Pain Head. Rep. 2018; 22: 27. DOI: 10.1007/s11916-018-0682-8
  40. Kurth T. Migraine a marker of vascular health? Cephalalgia. 2013; 33: 226–7. DOI: 10.1177/0333102412472074
  41. Winsvold B.S., Bettella F., Witoelar A., Anttila V., Gormley P., Kurth T. et al. Shared genetic risk between migraine and coronary artery disease: a genome-wide analysis of common variants. PLoS One. 2017; 12: e0185663. DOI: 10.1371/journal.pone.0185663
  42. Winsvold B.S., Nelson C.P., Malik R., Gormley P., Anttila V., Vander Heiden J. et al. Genetic analysis for a shared biological basis between migraine and coronary artery disease. Neurol. Gen. 2015; 1: e10. DOI: 10.1212/nxg.0000000000000010
  43. Malik R., Freilinger T., Winsvold B.S., Anttila V., Vander Heiden J., Traylor M. et al. Shared genetic basis for migraine and ischemic stroke: a genome-wide analysis of common variants. Neurology. 2015; 84: 2132–45. DOI: 10.1212/wnl.0000000000001606
  44. Pickrell J.K., Berisa T., Liu J.Z., Segurel L., Tung J.Y., Hinds D.A. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Gen. 2016; 48: 709–17. DOI: 10.1038/ng.3570
  45. Азимова Ю.Э., Климов Е.А., Скоробогатых К.В., Сергеев А.В., Кокаева З.Г., Табеева Г.Р. Генетические основы гемиплегической мигрени. Медицинская генетика. 2013; 12 (4): 3–7.
  46. Ruff R.L., Ruff S.S., Wang X.-F. Headaches among operation iraqi freedom/operation enduring freedom veterans with mild traumatic brain injury associated with exposures to explosions. J. Rehabil. Res. Dev. 2008; 45 (7): 941–52. DOI: 10.1682/JRRD.2008.02.0028
  47. Филатова Е.Г., Осипова В.В., Табеева Г.Р., Парфенов В.А., Екушева Е.В., Азимова Ю.Э. и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2020; 12 (4): 4–14. DOI: 10.14412/2074-2711-2020-4-4-14
  48. Шумилина М.В., Бузиашвили Ю.И. Нарушения венозного церебрального кровообращения у больных с сердечно-сосудистыми заболеваниями. Клиническая физиология кровообращения. 2004; 2: 44–53.
  49. Бокерия Л.А., Бузиашвили Ю.И., Шумилина М.В. Нарушения венозного церебрального кровообращения у больных с сердечно-сосудистой патологией (головная боль, ишемия, артериосклероз). М: Изд-во НЦССХ им. А.Н. Бакулева РАМН; 2003.
  50. Горбунова Е.В., Шумилина М.В. Дефект межпредсердной перегородки и цефалгический синдром. Клиническая физиология кровообращения. 2009; 2: 24–30.
****
  1. Vos Th., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M. et al. Years lived with disability squealed of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859): 2163–96. DOI: 10.1016/S0140-6736(12)61729-2
  2. GBD 2015 Neurological Disorders Collaborator Group Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017; 16 (11): 877–89.
  3. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018; 38 (1): 1–211. DOI: 10.1177/0333102417738202
  4. Sacco S., Ornello R., Ripa P., Tiseo C., Degan D., Pistoia F. et al. Migraine and risk of ischaemic heart disease: a systematic review and meta-analysis of observational studies. Eur. J. Neurol. 2015; 22: 1001–11. DOI: 10.1111/ene.12701
  5. Kurth T., Winter A.C., Eliassen A.H., Dushkes R., Mukamal K.J., Rimm E.B. et al. Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ. 2016; 353: i2610. DOI: 10.1136/bmj.i2610 6. Linstra K.M., Ibrahimi K., Terwindt G.M., Wermer M.J.H., MaassenVanDenBrink A. Migraine and cardiovascular disease in women. Maturitas. 2017; 97: 28–31. DOI: 10.1016/j.maturitas.2016.12.008
  6. Mahmoud A.N., Mentias A., Elgendy A.Y., Qazi A., Barakat A.F., Saad M. et al. Migraine and the risk of cardiovascular and cerebrovascular events: a metaanalysis of 16 cohort studies including 1 152 407 subjects. BMJ. 2018; 8: e020498. DOI: 10.1136/bmjopen2017-020498
  7. Adelborg K., Szépligeti S.K., Holland-Bill L., Ehrenstein V., Horváth-Puhó E., Henderson V.W. et al. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study. BMJ. 2018; 360: k96. DOI: 10.1136/bmj.k96 9. Sen S., Androulakis X.M., Duda V., Alonso A., Chen L.Y., Soliman E.Z. et al. Migraine with visual aura is a risk factor for incident atrial fibrillation: a cohort study. Neurology. 2018; 91: e2202–10. DOI: 10.1212/WNL.0000000000006650
  8. Elgendy I.Y., Nadeau S.E., Merz C.N., Pepine C.J. Migraine headache: an under-appreciated risk factor for cardiovascular disease in women. J. Am. Heart Ass. 2019; 8: e014546. DOI: 10.1161/JAHA.119.014546
  9. Saeed A., Rana K.F., Warriach Z.I., Tariq M.A. Association of migraine and ischemic heart disease: a review. Cureus. 2019; 11 (9): e5719. DOI: 10.7759/cureus.5719
  10. Kurth T., Rohmann J.L., Shapiro R.E. Migraine and risk of cardiovascular disease. BMJ. 2018; 360: k275. DOI: 10.1136/bmj.k275
  11. Hippisley-Cox J., Coupland C., Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017; 357: j2099. DOI: 10.1136/bmj.j2099
  12. O/ie L.R., Kurth T., Gulati S., Dodick D.W. Migraine and risk of stroke. J. Neurol. Neurosurg. Psych. 2020; 91: 593–604. DOI: 10.1136/jnnp-2018-318254
  13. Elseweidy M.M. The cause of the morning headache is a violation of the venous outflow from the head due to the oncoming flow therapeutic potential of 10-DHGD and/or Pentoxifyllin against aorta calcification in high dietary cholesterol-fed rabbits. Abstract. In: Second International Conference on Dental and Oral Health. 2018, November 26–27; Madrid, Spain.
  14. Ermoshkin V.I. The cause of the morning headache is a violation of the venous outflow from the head due to the oncoming flow. J. Biomed. Pharm. Sci. 2018; 1 (2): 113–5. 17. Ermoshkin V.I. The new theory of heart failure. London; 2017: 15–7. http://heartcongress.conference series.com/europe/abstract/2017/the-new-theoryofheart-failure (дата обращения 17.03.2017)
  15. Folsom A.R., Lutsey P.L., Misialek J.R., Cushman M. A prospective study of migraine history and venous thromboembolism in older adults. Res. Pract. Thromb. Haemost. 2019; 3 (3): 357–63. DOI: 10.1002/rth2.12200
  16. Siegerink B., Rohmann J.L. Impact of your results: beyond the relative risk. Res. Pract. Thromb. Haemost. 2018; 2: 653–57. DOI: 10.1002/rth2.12148 20. Siegerink B., Adelborg K. Migraine and venous thrombosis: another important piece of the puzzle. Res. Pract. Thromb. Haemost. 2019; 3 (3): 309–11. DOI: 10.1002/rth2.12209
  17. Peng K.P., Chen Y.T., Fuh J.L., Tang C.H., Wang S.J. Association between migraine and risk of venous thromboembolism: a nationwide cohort study. Headache. 2016; 56: 1290–9. DOI: 10.1111/head.12885
  18. Asvestas D., Vlachos K., Salachas A., Letsas K.P., Sideris A. Headache: an unusual presentation of acute myocardial infraction. World J. Cardiol. 2014; 6: 514–6. DOI: 10.4330/wjc.v6.i6.514
  19. Wassef N., Ali A.T., Katsanevaki A.Z., Nishtar S. Cardiac cephalgia. Cardiol. Res. 2014; 5: 195–7. DOI: 10.14740/cr361w
  20. Chowdhury A.W., Saleh M.A.D., Hasan P., Amin M.G., Khan T.A., Sabah K.M.N., Kabir S.R. Cardiac cephalgia: a headache of the heart. J. Cardiol. Cases. 2015; 11: 139–41. DOI: 10.1016/j.jccase.2015.02.002
  21. Huang C.C., Liao P.C. Heart attack causes headache – cardiac cephalalgia. Acta Cardiol. Sin. 2016; 32: 239–42. DOI: 10.6515/acs20150628a
  22. MacIsaac R., Jarvis S., Busche K. A case of a cardiac cephalgia. Can. J. Neurol. Sci. 2019; 46: 124–6. DOI: 10.1017/cjn.2018.377
  23. Dell’Aquila A., Sciatti E., Vizzardi E., Metra M. The brain-heart connection: a multiple sclerosis relapse presenting as Takotsubo Syndrome. A case report and literature review. Monaldi Arch. Chest. Dis. 2020; 90 (1): 143–7. DOI: 10.4081/monaldi.2020.1153
  24. Bi Y.C., Gong L. Headache and sick sinus syndrome: a case report. World J. Clin. Cases. 2020; 8 (12): 2629–33. DOI: 10.12998/wjcc.v8.i12.2629
  25. Takagi H., Umemoto T. A meta-analysis of case-control studies of the association of migraine and patent foramen ovale. J. Cardiol. 2016; 67: 493–503. DOI: 10.1016/j.jjcc.2015.09.016
  26. West B.H., Noureddin N., Mamzhi Y., Low C.G., Coluzzi A.C., Shih E.J. et al. Frequency of patent foramen ovale and migraine in patients with cryptogenic stroke. Stroke. 2018; 49: 1123–8. DOI: 10.1161/strokeaha.117.020160 31. Biasco L., Infantino V., Orzan F., Vicentini S., Rovera Ch., Longo G. et al. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt. Am. J. Cardiol. 2014; 64: 390–4. DOI: 10.1016/j.jjcc.2014.02.023
  27. Mattle H.P., Evers S., Hildick-Smith D., Becker W.J., Baumgartner H., Chataway J. et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial. Eur. Heart J. 2016; 37: 2029–36. DOI: 10.1093/eurheartj/ehw027
  28. Tobis J.M., Charles A., Silberstein S.D., Sorensen S., Maini B., Horwitz Ph.A. et al. Percutaneous closure of patent foramen ovale in patients with migraine: the premium trial. J. Am. Coll. Cardiol. 2017; 70: 2766–74. DOI: 10.1016/j.jacc.2017.09.1105
  29. Sommer R.J., Nazif T., Privitera L., Robbins B.T. Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale. Neurology. 2018; 91: 1002–09. DOI: 10.1212/WNL.0000000000006572
  30. Androulakis X.M., Kodumuri N., Giamberardino L.D., Rosamond W.D., Gottesman R.F., Yim E. et al. Ischemic stroke subtypes and migraine with visual aura in the ARIC study. Neurology. 2016; 87: 2527–32. DOI: 10.1212/WNL.0000000000003428
  31. Табеева Г.Р. Головная боль: Руководство для врачей. 2-е изд., перераб. и доп. М.: ГЭОТАР-Медиа; 2018. [Tabeeva G.R. Headache: Guide for doctors. 2nd ed., reprint. and add. Moscow: GEOTAR-Media; 2018 (in Russ.).
  32. Табеева Г.Р. Головная боль. М.: ГЭОТАР-Медиа; 2020. https://www.rosmedlib.ru/book/ISBN 9785970458648.html (дата обращения 10.11.2020) [Tabeeva G.R. Headache. Moscow: GEOTAR-Media; 2020 (in Russ.). https://www.rosmedlib.ru/book/ISBN9785970458648.html (accessed 10.11.2020)
  33. Ramadan N.M. Headache caused by raised intracranial pressure and intracranial hypotension. Curr. Opin. Neurol. 1996; 9: 214–8. DOI: 10.1097/00019052- 199606000-00011 39. Lipton R.B., Lowenkopf T., Bajwa Z.H., Leckie R.S., Ribeiro S., Newman L.C., Greenberg M.A. Cardiac cephalgia: a treatable form of exertional headache. Neurology. 1997; 49: 813–6. DOI: 10.1212/wnl.49.3.813
  34. Bini A., Evangelista A., Castellini P., Lambru G., Ferrante T., Manzoni G.C., Torelli P. Cardiac cephalgia. J. Headache Pain. 2009; 10: 3–9. DOI: 10.1007/s10194-008-0087-x
  35. Sacco S., Ripa P., Grassi D., Pistoia F., Ornello R., Carolei A. et al. Peripheral vascular dysfunction in migraine: a review. J. Head. Pain. 2013; 14: 80. DOI: 10.1186/1129-2377-14-80
  36. Butt J.H., Franzmann U., Kruuse C. Endothelial function in migraine with aura – a systematic review. Headache. 2015; 55: 35–54. DOI: 10.1111/head.12494
  37. Rambarat C., Elgendy I., Johnson B., Reis S.E., Thompson D.V., Sharaf B.L. et al. Migraine headache and long-term cardiovascular outcomes: an extended follow-up of the women’s ischemia syndrome evaluation. Am. J. Med. 2017; 130: 738–43. DOI: 10.1016/j.amjmed.2016.12.028
  38. Tietjen G.E., Khubchandani J. Vascular biomarkers in migraine. Cephalalgia. 2015; 35: 95–117. DOI: 10.1177/0333102414544976 45. Tietjen G.E., Collins S.A. Hypercoagulability and migraine. Headache. 2018; 58: 173–83. DOI: 10.1111/head.13044
  39. Iljazi A., Ayata C., Ashina M., Hougaard A. The role of endothelin in the pathophysiology of migraine – a systematic review. Curr. Pain Head. Rep. 2018; 22: 27. DOI: 10.1007/s11916-018-0682-8
  40. Kurth T. Migraine a marker of vascular health? Cephalalgia. 2013; 33: 226–7. DOI: 10.1177/0333102412472074
  41. Winsvold B.S., Bettella F., Witoelar A., Anttila V., Gormley P., Kurth T. et al. Shared genetic risk between migraine and coronary artery disease: a genome-wide analysis of common variants. PLoS One. 2017; 12: e0185663. DOI: 10.1371/journal.pone.0185663
  42. Winsvold B.S., Nelson C.P., Malik R., Gormley P., Anttila V., Vander Heiden J. et al. Genetic analysis for a shared biological basis between migraine and coronary artery disease. Neurol. Gen. 2015; 1: e10. DOI: 10.1212/nxg.0000000000000010
  43. Malik R., Freilinger T., Winsvold B.S., Anttila V., Vander Heiden J., Traylor M. et al. Shared genetic basis for migraine and ischemic stroke: a genome-wide analysis of common variants. Neurology. 2015; 84: 2132–45. DOI: 10.1212/wnl.0000000000001606
  44. Pickrell J.K., Berisa T., Liu J.Z., Segurel L., Tung J.Y., Hinds D.A. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Gen. 2016; 48: 709–17. DOI: 10.1038/ng.3570
  45. Azimova J.E., Klimov E.A., Skorobogatykh K.V., Sergeev A.V., Kokaeva Z.G., Tabeeva G.R. Hemiplegic migraine. Medical Genetics. 2013; 12 (4): 3–7 (in Russ.).
  46. Ruff R.L., Ruff S.S., Wang X.-F. Headaches among operation iraqi freedom/operation enduring freedom veterans with mild traumatic brain injury associated with exposures to explosions. J. Rehabil. Res. Dev. 2008; 45 (7): 941–52. DOI: 10.1682/JRRD.2008.02.0028
  47. Filatova E.G., Osipova V.V., Tabeeva G.R., Parfenov V.A., Ekusheva E.V., Azimova Yu.E. et al. Diagnosis and treatment of migraines: recommendations of Russian experts. Neurology, Neuropsychiatry, Psychosomatics. 2020; 12 (4): 4–14 (in Russ.). DOI: 10.14412/2074-2711-2020-4-4-14
  48. Shumilina M.V., Buziashvili Yu.I. Disorders of venous cerebral circulation in patients with cardiovascular diseases. Clinical Physiology of Circulation. 2004; 2: 44–53 (in Russ.).
  49. Bockeria L.A., Buziashvili Yu.I., Shumilina M.V. Disorders of venous cerebral circulation in patients with cardiovascular pathology (headache, ischemia, arteriosclerosis). Moscow; 2003 (in Russ.).
  50. Gorbunova E.V., Shumilina M.V. MPP defect and cephalgic syndrome. Clinical Physiology of Circulation. 2009; 2: 24–30 (in Russ.).

Об авторах

  • Емец Екатерина Викторовна, аспирант кафедры кардиологии и функциональной диагностики, врач функциональной диагностики; ORCID
  • Шумилина Маргарита Владимировна, доктор мед. наук, профессор кафедры кардиологии и функциональной диагностики, заведующая группой ультразвуковой диагностики сердечно-сосудистой и органной патологии; ORCID

 Если вы заметили опечатку, выделите текст и нажмите Alt+A